Tag: Pandemic

Browse our exclusive articles!

Discover How This Man Used ChatGPT to Purchase Groceries on a Budget

Discover how Ammaar Reshi, a techpreneur from the UK, used OpenAI's advanced ChatGPT to write a children's book, and craft a budget-friendly shopping experience with the help of Instacart! Learn how he harnessed AI to navigate through everyday needs, and get an insight into the potential of Artificial Intelligence.

ChatGPT Gets Competition from Alibaba — Supports Languages English and Chinese

This article explores the exciting trend of generative AI with OpenAI's ChatGPT, and how it will be used by Microsoft, Google, and Alibaba. Learn how Alibaba launched a new AI model equipped with language capabilities in both Chinese and English, and how it has drastically increased the potential of what artificial intelligence can do for businesses in this ever-evolving world.

Quantexa Secures $129M Investment: Valuation Reaches $1.8B to Combat Online Fraud and Manage Customer Data

. Quantexa, the AI-powered business intelligence and risk analytics company, has secured a $129 million Series E round led by Singapore's sovereign wealth fund GIC, valuing the firm at $1.8 billion. With hundreds of customers in 70+ countries, previous investors, and recent acquisitions, Quantexa is on a profitable journey in the risk and compliance tech market.

Expanding Recruiting Beyond the Ivies Could Be Advantageous for Wall Street

This article shares the remarkable story of SUNY Albany graduate Matthew Alfieri and his journey to Wall Street without an Ivy-league pedigree. With hard work, a little luck and a lot of chutzpah, he proves that access to the elite world of Wall Street is attainable from any school. Recruiting beyond Ivy and prep schools could result in higher profits & better working relationships.

Popular

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.

Pioneering Research Uncovers Vital Biomarker for Orbital Inflammation

An in-depth study reveals HLF as a potential biomarker for orbital inflammation, offering new insights for diagnosis and treatment strategies.

Subscribe

spot_imgspot_img